Receptors for angiotensin II and III in rat adrenals. 1977

M A Devynck, and V Koreve, and P G Matthews, and P Meyer, and M G Pernollet

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D005260 Female Females
D000311 Adrenal Glands A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS. Adrenal Gland,Gland, Adrenal,Glands, Adrenal
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000805 Angiotensin III A heptapeptide formed from ANGIOTENSIN II after the removal of an amino acid at the N-terminal by AMINOPEPTIDASE A. Angiotensin III has the same efficacy as ANGIOTENSIN II in promoting ALDOSTERONE secretion and modifying renal blood flow, but less vasopressor activity (about 40%). Des-Asp Angiotensin II,Des-Aspartyl-Angiotensin II,Angiotensin II, Des-Asp,Des Asp Angiotensin II,Des Aspartyl Angiotensin II
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M A Devynck, and V Koreve, and P G Matthews, and P Meyer, and M G Pernollet
September 1977, Proceedings of the National Academy of Sciences of the United States of America,
M A Devynck, and V Koreve, and P G Matthews, and P Meyer, and M G Pernollet
January 1980, Problemy endokrinologii,
M A Devynck, and V Koreve, and P G Matthews, and P Meyer, and M G Pernollet
December 1997, Endocrinology,
M A Devynck, and V Koreve, and P G Matthews, and P Meyer, and M G Pernollet
October 1995, Molecular and cellular endocrinology,
M A Devynck, and V Koreve, and P G Matthews, and P Meyer, and M G Pernollet
June 1976, Circulation research,
M A Devynck, and V Koreve, and P G Matthews, and P Meyer, and M G Pernollet
March 1980, Biochemical pharmacology,
M A Devynck, and V Koreve, and P G Matthews, and P Meyer, and M G Pernollet
March 2006, Hypertension (Dallas, Tex. : 1979),
M A Devynck, and V Koreve, and P G Matthews, and P Meyer, and M G Pernollet
July 1994, Clinical and experimental pharmacology & physiology,
M A Devynck, and V Koreve, and P G Matthews, and P Meyer, and M G Pernollet
June 1984, Brain research,
M A Devynck, and V Koreve, and P G Matthews, and P Meyer, and M G Pernollet
April 1977, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
Copied contents to your clipboard!